Company registration number 13534059 (England and Wales)
Ataraxia 9 Limited
Unaudited financial statements
For the period ended 31 December 2024
Ataraxia 9 Limited
Contents
Page
Statement of financial position
1 - 2
Notes to the financial statements
3 - 7
Ataraxia 9 Limited
Statement of financial position
As at 31 December 2024
31 December 2024
- 1 -
31 December 2024
30 June 2023
Notes
£
£
£
£
Fixed assets
Investments
3
1,198,880
1,326,370
Current assets
Debtors
4
1,667,166
1,382,910
Cash at bank and in hand
34,420
82,938
1,701,586
1,465,848
Creditors: amounts falling due within one year
5
(2,988,471)
(2,565,956)
Net current liabilities
(1,286,885)
(1,100,108)
Total assets less current liabilities
(88,005)
226,262
Creditors: amounts falling due after more than one year
6
-
(222,490)
Net (liabilities)/assets
(88,005)
3,772
Capital and reserves
Called up share capital
1,000
1,000
Profit and loss reserves
(89,005)
2,772
Total equity
(88,005)
3,772
Ataraxia 9 Limited
Statement of financial position (continued)
As at 31 December 2024
31 December 2024
- 2 -

For the financial period ended 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the income statement within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 1 July 2025 and are signed on its behalf by:
Mr C Parker
Director
Company registration number 13534059 (England and Wales)
Ataraxia 9 Limited
Notes to the financial statements
For the period ended 31 December 2024
- 3 -
1
Accounting policies
Company information

Ataraxia 9 Limited is a private company limited by shares incorporated in England and Wales. The registered office is Venture House, St. Leonards Road, Allington, Maidstone, England, ME16 0LS.

1.1
Reporting period

The financial statements presented are for an extended period. The period was extended to bring the year end in line with other connected companies. Therefore, the comparative results for the year ended 30 June 2023 are not entirely comparable.

1.2
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.3
Going concern

Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company is reliant on ongoing support from the directors and the directors are committed to this ongoing support. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.4
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that are recoverable.

1.5
Fixed asset investments

Interests in subsidiaries are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

1.6
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

Ataraxia 9 Limited
Notes to the financial statements (continued)
For the period ended 31 December 2024
1
Accounting policies
(Continued)
- 4 -
1.7
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors and loans from fellow group companies, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.8
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.9
Taxation

The tax expense represents the sum of the tax currently payable.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Ataraxia 9 Limited
Notes to the financial statements (continued)
For the period ended 31 December 2024
1
Accounting policies
(Continued)
- 5 -
1.10
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

2
Employees

The average monthly number of persons (including directors) employed by the company during the period was:

2024
2023
Number
Number
Total
0
3
3
Fixed asset investments
2024
2023
£
£
Shares in group undertakings and participating interests
1,198,880
1,326,370
Movements in fixed asset investments
Shares in subsidiaries
£
Cost or valuation
At 1 July 2023
1,326,370
Disposals
(127,490)
At 31 December 2024
1,198,880
Carrying amount
At 31 December 2024
1,198,880
At 30 June 2023
1,326,370
Ataraxia 9 Limited
Notes to the financial statements (continued)
For the period ended 31 December 2024
- 6 -
4
Debtors
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
-
0
14,151
Other debtors
1,667,166
1,368,759
1,667,166
1,382,910

The loans included in other debtors is unsecured and interest is being charged at 8.5% above the Bank of England base rate.

5
Creditors: amounts falling due within one year
2024
2023
£
£
Trade creditors
2,500
-
0
Taxation and social security
68,939
17,458
Other creditors
2,917,032
2,548,498
2,988,471
2,565,956
6
Creditors: amounts falling due after more than one year
2024
2023
£
£
Other creditors
-
0
222,490
7
Security

The loan included in other borrowings is unsecured and interest is being charges at 8.5% above the Bank of England base rate capped at 10%.

 

The loans included in other creditors are unsecured and interest is being charged at 3% per annum above the Bank of England base rate.

Ataraxia 9 Limited
Notes to the financial statements (continued)
For the period ended 31 December 2024
- 7 -
8
Related party transactions

At the year end date the company owed £1,882,099 (2023 - £1,666,806) to P. G. Cullum. As at the year end date unpaid interest of £384,453 (2023 - £85,859) was accrued on these loan notes.

 

At the year end date the company owed £544,283 (2023 - £542,000) to connected companies. £542,500 is unsecured and interest is being charges at 3% per annum above the Bank of England base rate. The remaining is interest free and is repayable on demand.

 

At the year end date the company was due £1,537,873 (2023 - £1,267,301) from a subsidiary. This is unsecured and interest is being charged at 8.5% per annum above the Bank of England base rate.

 

At the year end date the company was due £129,293 (2023 - £41,000) from a connected company. This is unsecured and is repayable on demand.

2024-12-312023-07-01falsefalsefalse01 July 2025CCH SoftwareCCH Accounts Production 2025.200No description of principal activityMr Christian ParkerMr David Alexander Lewis ClappMr P G Cullum135340592023-07-012024-12-31135340592024-12-31135340592023-06-3013534059core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3113534059core:CurrentFinancialInstrumentscore:WithinOneYear2023-06-3013534059core:ShareCapital2024-12-3113534059core:ShareCapital2023-06-3013534059core:RetainedEarningsAccumulatedLosses2024-12-3113534059core:RetainedEarningsAccumulatedLosses2023-06-3013534059bus:Director12023-07-012024-12-31135340592022-07-012023-06-3013534059core:CurrentFinancialInstruments2024-12-3113534059core:CurrentFinancialInstruments2023-06-3013534059core:WithinOneYear2024-12-3113534059core:WithinOneYear2023-06-3013534059core:Non-currentFinancialInstruments2024-12-3113534059core:Non-currentFinancialInstruments2023-06-3013534059bus:PrivateLimitedCompanyLtd2023-07-012024-12-3113534059bus:SmallCompaniesRegimeForAccounts2023-07-012024-12-3113534059bus:FRS1022023-07-012024-12-3113534059bus:AuditExemptWithAccountantsReport2023-07-012024-12-3113534059bus:Director22023-07-012024-12-3113534059bus:Director32023-07-012024-12-3113534059bus:FullAccounts2023-07-012024-12-31xbrli:purexbrli:sharesiso4217:GBP